Eisai

4523.TSE

29.50 USD

-0.08

-0.27%

Overview

Last close

29.50 usd

Market cap

8.32B usd

52 week high

36.12 usd

52 week low

24.09 usd

Target price

32.22 usd

Valuation

P/E

26.5607

Forward P/E

32.6797

Price/Sales

1.6205

Price/Book Value

1.482

Enterprise Value

7.80B usd

EV/Revenue

1.5278

EV/EBITDA

11.1654

Key financials

Revenue TTM

5.13B usd

Gross Profit TTM

3.99B usd

EBITDA TTM

564.81M usd

Earnings per Share

1.11 usd

Dividend

1.02 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.